# Haichang Biotech

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/haichang-biotech

- Industry: Pharmaceuticals
- Headquarters: Hangzhou, China
- Website: www.zhejianghaichang.com
- Total disclosed funding: $70M
- Latest round: Series C (Aug 11, 2025)
- Investors on record: 5

## About

Founded in 2013 and based in Hangzhou, China, Haichang Biotech specializes in the technological development and industrial application of drug delivery systems, with a product pipeline covering multiple areas including antitumor, tumor immunotherapy, analgesia, and infectious disease prevention. In August 2025, Haichang Biotech raised approximately CNY 500 million in Series C funding led by new investor SDIC Venture Capital, new investors CCB Investment Funds Management, Dongguan Songshan Lake Science City Venture Capital Co., Ltd, Sinovac Biotech Co. Ltd., ZJ Biomedicine and High-end Equipment Industry Fund with participation from other investors. Zhejiang Haichang Biopharmaceutical Technology Co., Ltd. specializes in developing innovative biopharmaceutical technologies, focusing on small nucleic acid drugs and lipid nanoparticles. Their product pipeline includes advanced therapeutic solutions aimed at enhancing efficacy in treating various diseases. The company serves a diverse clientele, including hospitals and pharmaceutical firms, across Asia, Europe, and North America, integrating research, production, and sales capabilities to position itself within the biotech sector. The company generates revenue through the research and development of technological development, industrial application of drug delivery systems and the sale of other related products. The funding raised in August 2025 will be used to focus on the development and clinical trials of its innovative nucleic acid drug pipeline and novel extrahepatic delivery systems, as well as accelerating the development of its production base and capacity.

## Funding rounds

- Series C, Aug 11, 2025, $70M — Sinovac Biotech Co. Ltd., SDIC Venture Capital, CCB Investment Funds Management, ZJ Biomedicine and High-end Equipment Industry Fund, Dongguan Songshan Lake Science City Venture Capital Co., Ltd

## Investors

- Sinovac Biotech Co. Ltd. — Series C
- SDIC Venture Capital (https://capitalatlas.ai/funds/sdic-venture-capital) — Series C
- CCB Investment Funds Management (https://capitalatlas.ai/funds/ccb-investment-funds-management) — Series C
- ZJ Biomedicine and High-end Equipment Industry Fund — Series C
- Dongguan Songshan Lake Science City Venture Capital Co., Ltd — Series C